These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36709094)

  • 21. DNA base editing in nuclear and organellar genomes.
    Tan J; Forner J; Karcher D; Bock R
    Trends Genet; 2022 Nov; 38(11):1147-1169. PubMed ID: 35853769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research Progress on Application of CRISPR/Cas Genome Editing Technology in Hematological Diseases -Review].
    Xin LY; Liu AF; Zhong SS; Chen YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1284-8. PubMed ID: 27531817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
    Dhokane D; Bhadra B; Dasgupta S
    Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA-Dependent RNA Targeting by CRISPR-Cas Systems: Characterizations and Applications.
    Gunitseva N; Evteeva M; Borisova A; Patrushev M; Subach F
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome Editing: Past, Present, and Future.
    Carroll D
    Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-Enabled Tools for Engineering Microbial Genomes and Phenotypes.
    Tarasava K; Oh EJ; Eckert CA; Gill RT
    Biotechnol J; 2018 Sep; 13(9):e1700586. PubMed ID: 29917318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
    Giersch RM; Finnigan GC
    Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fine-Tuning Next-Generation Genome Editing Tools.
    Kanchiswamy CN; Maffei M; Malnoy M; Velasco R; Kim JS
    Trends Biotechnol; 2016 Jul; 34(7):562-574. PubMed ID: 27167723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Review of CRISPR-Based Genome Editing: Survival, Evolution and Challenges.
    Ahmad HI; Ahmad MJ; Asif AR; Adnan M; Iqbal MK; Mehmood K; Muhammad SA; Bhuiyan AA; Elokil A; Du X; Zhao C; Liu X; Xie S
    Curr Issues Mol Biol; 2018; 28():47-68. PubMed ID: 29428910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current technological interventions and applications of CRISPR/Cas for crop improvement.
    Shah P; Magar ND; Barbadikar KM
    Mol Biol Rep; 2022 Jun; 49(6):5751-5770. PubMed ID: 34807378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Tale of Two Moieties: Rapidly Evolving CRISPR/Cas-Based Genome Editing.
    Yang L; Chen J
    Trends Biochem Sci; 2020 Oct; 45(10):874-888. PubMed ID: 32616331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative analysis of lipid-mediated CRISPR-Cas9 genome editing techniques.
    Ringer KP; Roth MG; Garey MS; Piorczynski TB; Suli A; Hansen JM; Alder JK
    Cell Biol Int; 2018 Jul; 42(7):849-858. PubMed ID: 29457665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Decade of CRISPR-Cas Gnome Editing in
    Kim HM; Hong Y; Chen J
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines.
    Tang N; Zhang Y; Shen Z; Yao Y; Nair V
    CRISPR J; 2021 Aug; 4(4):477-490. PubMed ID: 34406035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.